Στείλτε το σ' έναν φίλο
RSS
google +
Εκτύπωση

Νέα (Εμβολιασμός)

This section on health in the EU has been created as a trustworthy gateway to a wide range of information and data on health-related issues and activities at both European, national and international level. The content is produced by the European Commission, the Member States of the EU and the European Economic Area (EEA), plus EU candidate countries; by international organisations; and by pan-European non-governmental organisations in the area of public health.

Seasonal influenza vaccines 2014–2015 provide protection against circulating flu viruses    who.int

Vaccination against seasonal influenza is particularly important for older people, pregnant women, those with underlying health problems, such as asthma or cardiovascular disease, and health care wor[...]

Parkinson's Vaccine: EU-Team Launches Clinical Trial    epda.eu.com

A novel Parkinson's vaccine will now be tested in a clinical Phase I trial in Austria by an EU-funded consortium. The vaccine was developed by the Austrian biotech company AFFiRiS AG and targets a pr[...]

No evidence that Fluad vaccine caused deaths in Italy    europa.eu

EMA Committee review reassures Member States over safety of flu vaccine[...]

The prevalence of Parkinson's disease: A systematic review and meta-analysis    epda.eu.com

Authors sought to synthesize studies on the prevalence of PD to obtain an overall view of how the prevalence of this disease varies by age, by sex, and by geographic location.[...]

Investigation into reports of serious adverse events following use of Fluad    europa.eu

EU regulatory authorities following up on suspension of two batches of flu vaccine in Italy[...]

Success Stories - Simulating the body's immune defences    europa.eu

T-cells are white blood cells that circulate in the body, scanning for cellular abnormalities and infections. Sometimes the detecting process goes awry and the T-cells mistakenly attack the body's ow[...]

Success Stories - Expanding insight into Alzheimer's disease    europa.eu

Chronic neurodegenerative diseases, such as Alzheimer's, Parkinson's and Huntington's, are all characterised by an inflammatory reaction within the brain. Until now, some of the factors behind this r[...]

New grants for molecular approaches for foodborne pathogens and read across methods for chemical hazards    europa.eu

Published on: 12 November 2014 New grants for molecular approaches for foodborne pathogens and read across methods for chemical hazards[...]

Parkinson's disease incidence and prevalence assessment in France using the national healthcare insurance database    epda.eu.com

Conclusions: The specific and sensitive definitions of disease bracket the true values; the relatively small range indicates that the current study provides good estimations of incidence and prevalen[...]

Imaging prodromal Parkinson disease: The Parkinson Associated Risk Syndrome Study    epda.eu.com

Conclusion: Subjects with DAT deficit who do not meet criteria for a diagnosis of PD can be identified by olfactory testing. Sequential biomarker assessment may identify those at risk of PD.[...]

Scholarships for MSc programma in vaccinology in Siena, Italy    edctp.org

The University of Siena Medical School, Novartis Vaccines and Diagnostics, Novartis Vaccines Institute for Global Health (NVGH), and the ADITEC (Advanced Immunization Technologies) programme invite a[...]

Call for proposals: 'Global Alliance for Chronic Diseases. Prevention and treatment of lung diseases'    europa.eu

Research Participant Portal is your entry point for electronic administration of EU-funded research and innovation projects[...]

Revised framework for development of influenza vaccines    europa.eu

EMA releases third and final module for public consultation[...]

Scientific guideline: Draft guideline on influenza vaccines – submission and procedural requirements, draft: consultation open    europa.eu

The need to update the current guidelines regarding the development of influenza vaccines was recognised in the wake of the 2009-2010 influenza pandemic, as the Agency conducted its [...]

Influenza: common questions answered    who.int

WHO recommends that people with a higher risk of developing serious health complications as a result of influenza be vaccinated against seasonal influenza every autumn. Because health care workers ar[...]

EMA advises on development plan for GSK Ebola vaccine    europa.eu

Developers encouraged to request accelerated procedure for scientific advice[...]

Crown Princess Mary of Denmark underlines importance of universal vaccination in address to Tajik medical students    who.int

Today, on World Polio Day, as part of her visit to Tajikistan to draw attention to maternal and child health issues throughout the WHO European Region, HRH Crown Princess Mary of Denmark underlined t[...]

European Union to boost Ebola research with €24.4 million    europa.eu

Commission Press release Brussels, 23 October 2014 European The European Commission has today announced €24.4 million from the EU budget for urgently needed Ebola research. The funding will go to fiv[...]

EMA ready to start assessment of Ebola vaccines and treatments as soon as data are made available    europa.eu

Rapid scientific advice to speed up development[...]

Danish Crown Princess Mary to visit Tajikistan to promote mother and child health, immunization    who.int

Her Royal Highness Crown Princess Mary of Denmark will visit Tajikistan on 23-25 October 2014, as Patron of the WHO Regional Office for Europe. With Zsuzsanna Jakab, WHO Regional Director for Europe,[...]

Speeding up development of Ebola treatments and vaccines    europa.eu

EMA encourages companies to apply for orphan designation[...]

First clinical data of therapeutic Parkinson's disease vaccine encourages continued development    epda.eu.com

AFFiRiS AG announced today at a press conference in New York results of AFF008, a Phase I clinical trial of PD01A, a vaccine against Parkinson´s disease. PD01A is the first therapy against the protei[...]

Imaging prodromal Parkinson disease: The Parkinson Associated Risk Syndrome Study    epda.eu.com

Conclusion: Subjects with DAT deficit who do not meet criteria for a diagnosis of PD can be identified by olfactory testing. Sequential biomarker assessment may identify those at risk of PD.[...]

WHO delivers tetanus toxoid vaccine to Ukraine    who.int

On 26 September 2014, WHO delivered a second tranche of medicine to Kyiv. The shipment included 300 000 doses of tetanus toxoid (TT) vaccine, which will cover Ukraine's needs until the end of 2015.[...]

Statement regarding interim findings of WHO assessment of deaths of children in Idleb governorate, Syrian Arab Republic    who.int

A WHO assessment of the cause of the death of 15 children in rural Idleb, northern Syrian Arab Republic, has concluded that the most likely cause of the event was the incorrect use of a drug called A[...]

5th ESWI Influenza Conference highlights benefits of vaccination    epha.org

The fifth international influenza conference organised by EPHA member the European Scientific Working Group on Influenza (ESWI) took place in Riga on 14-17 September. A number of plenary and 'science[...]

Regulatory and procedural guideline: Paediatric investigation plan: Expected key elements and requirements for a new DTaP containing combination vaccine seeking marketing authorisation, draft: consultation open    europa.eu

This document defines the study outline that applicants should follow when preparing the PIP for a new diphtheria-tetanus-acellular pertussis containing combination vaccine (e.g. pentavalent, hexaval[...]

Avoiding duplication of clinical trials in children    europa.eu

Proposed single development plan for tetanus-diphtheria-pertussis vaccines is released for public consultation[...]

Highlights of RC64 day 3 – Adoption of action plans on vaccines and prevention of child maltreatment    who.int

Two far-reaching action plans - on vaccines and prevention of child maltreatment - were adopted, mapping the path for interventions in these areas until 2020.[...]

Events - The Developmentment & Manufacturing of Vaccines Conference 2014 - 3-4 December 2014, Brussels    europa.eu

Our expert speaker panel will present unpublished case studies against practical recommendations to provide you with opportunities to improve your analytical methods, manufacturing strategies, pre-cl[...]

Highlights of RC64 day 3 – Adoption of action plans on vaccines and prevention of child maltreatment    who.int

Two far-reaching action plans - on vaccines and prevention of child maltreatment - were adopted, mapping the path for interventions in these areas until 2020.[...]

Highlights of RC64 day 3 – Adoption of action plans on vaccines, prevention of child maltreatment, and food and nutrition    who.int

Three far-reaching action plans - on vaccines, prevention of child maltreatment, and food and nutrition - were adopted, mapping the path for interventions in these areas until 2020.[...]

Prevalence of Malnutrition in Patients with Parkinson's: Comparative Study with Healthy Controls using MNA questionnaire    epda.eu.com

Study findings indicate the same nutritional status among mild to moderate PD patients compared with healthy controls. However, more than a quarter of the PD population was found to be at risk of mal[...]

Disclaimer

The European Commission is solely responsible for information present on EU-level websites, information present in the Portal originated by the Commission. National-level information is provided by the Member States concerned and Member States are solely responsible for the accuracy of the information. Likewise, the European Commission is not responsible for information on non-governmental organisations and international organisations websites. The European Union is committed to user privacy. Read more concerning the Legal Notice.
Further questions can be answered through the Contact page. The Health-EU portal supports principles and measures to increase the credibility of information on the net. It complies with the HONcode standard for trustworthy health information: verify here.